HF (heart failure) study supports home-haemodynamic monitor:
This article was originally published in Clinica
Results from a pilot study evaluating the usefulness of Pulse Metric's DynaPulse's noninvasive home-haemodynamic monitor in managing and treating heart failure (HF) patients has produced positive results, the company has reported. The study of 10 patients has been underway for around six months. It revealed a significant benefit from home-haemodynamic monitoring in at least half of the patients by facilitating early intervention, improved patient management and patient compliance, and overall improved cost-effectiveness in managing, intervening, and treating the patients, says the San Diego, California firm. DynaPulse is to start a 50-patient study to further evaluate the technology in HF patients.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”